img img

Real-time Intelligence. Complete Transparency. Optimized Outcomes.

InteliSys Health's™ technological capabilities unlock the power of data to drive better insights making them actionable while cutting through the complexity, tapping the full potential of big data with ease. We use data in new ways to improve processes that drive interactive success through more precise patient engagement and do it all with products architected for healthcare with industry-leading speed, efficiency, and simplicity. Our systems master data, maximize data quality and integration, capture, transform and link structured and unstructured data from any source—across the domains of physical, social, e-commerce and mobile—to gain insight and drive more effective medical decisions with “real-time” reporting capabilities.

It’s an innovation the healthcare ecosystem has been waiting for—intelligent software that guides doctors, patients, payors, and employers to the lowest-priced prescription drugs with no middlemen, no gimmicks, and no drug discount cards, mobile apps or websites to use.

InteliSys Health is revolutionizing healthcare with the industry’s first “real-time” prescription transparency platform, seamlessly integrated into the e-prescribing workflow to deliver drug price visibility and affordability.

Our Solutions

logo

RxStream™ is a breakthrough solution that connects doctors, patients, commercial-employer payors and pharmacies to deliver the lowest cost on prescription drugs through the e-prescribing workflow. It’s four unique capabilities combine to provide affordability and optimized medication adherence outcomes.

Leadership

man

Thomas Borzilleri
CEO/RxStream™ Inventor

View Bio
man

Stanley Crane
CTO

View Bio
man

Richard Karpeles
CFO

View Bio
man

Allen Crane
VP of Software Development

View Bio
man

Nancy Hughes
VP of Business Development

View Bio
man

Robert Picone
Business Development

View Bio
man

Holly Balchan
Business Development

View Bio

Advisory Board

man

Dale Renner
Advisor

View Bio
man

Dr. Timothy McKinney
Advisor

View Bio
man

Dr. Elizabeth Babin
Advisor

View Bio
man

Dr. Mitchell Zimmel
Advisor

View Bio
man

Robert Braner
Advisor

View Bio

News & Press

The CVS Health-Aetna deal: Are patients winners or losers? How will Amazon and Google react? 8 key questions answered

12/08/2017
The CVS Health-Aetna deal: Are patients winners or losers? How will Amazon and Google react? 8 key questions answered

CVS Health announced plans to acquire Aetna earlier this week for $69 billion, and leaders across healthcare are examining what the deal could mean for the industry going forward.

Jury is Out on Possible Effects of CVS/Aetna Merger-Could result in fewer choices for Aetna enrollees, observers say

12/06/2017
Jury is Out on Possible Effects of CVS/Aetna Merger-Could result in fewer choices for Aetna enrollees, observers say

If the proposed $69-billion purchase of health insurer Aetna by CVS -- a pharmacy chain that is also a pharmacy benefit manager (PBM) -- is approved, it may be good news for the companies involved, but its potential effects on patients and providers are not so clear, experts say.

Does Amazon Have What It Takes to Transform the Pharma Industry?

12/06/2017
Does Amazon Have What It Takes to Transform the Pharma Industry?

From basics like toilet paper to luxuries such as flatscreen TVs, Amazon can deliver just about anything to a doorstep these days—so, what about prescription drugs? That’s the question the company seems to be currently asking itself and is expected to announce its answer soon. 

Jeff Bezos, America’s patients need you to disrupt the drug industry

12/05/2017
Jeff Bezos, America’s patients need you to disrupt the drug industry

Dear Jeff Bezos –

Recent rumors that Amazon is considering entering the prescription drug business have that multi-billion-dollar industry quaking in its collective boots. And for good reason: Amazon has a reputation for exposing and driving down prices for the good of consumers.

CVS-Aetna Merger: Great for Shareholders and Catastrophic for Consumers

11/27/2017
CVS-Aetna Merger: Great for Shareholders and Catastrophic for Consumers

The rumored $66 billion merger of retail pharmacy CVS and health insurer Aetna holds strong potential to inflict financial pain on American patients by artificially inflating prescription drug prices while reducing transparency and competition.

Testimonials

Contact Us

Request a Demo